AGLagilon health, inc.

$82.66+185% 1Y

Is the price fair?

What AGL's price assumes

agilon health, inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 0.30× revenue.

0.30

Price / sales · no P/E: the last twelve months did not end in a profit

Price / book
7.86

Price / book · today's price, trailing year to Jun 30, 2026

EV / sales
0.29

EV / sales

Details›
Price / booktoday's price, trailing year to Jun 30, 2026
7.86
EV / EBIToperating margin −5.2%: the multiple describes the denominator
not meaningful
EV / salestoday's price, trailing year to Jun 30, 2026
0.29
Market capitalisation
$1.79B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.